Review

stt3a (Proteintech)

Proteintech is a verified supplier

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Proteintech stt3a

(A) Western blot showing the amplification of PK-resistant PrP Sc from brain homogenate PMCA reactions supplemented with DMSO or NGI-1. (B) Representative flow cytometry plot showing effect of siRNA knockdown of <t>Stt3a</t> , Stt3b , or Stt3a and Stt3b combination on surface PrP C levels in WT CAD5 cells. (C) Quantification of flow cytometry PrP C surface expression in undifferentiated CAD5 cells treated with siRNAs targeted at Stt3a , Stt3b , or Stt3a and Stt3b in combination. Points represent individual samples from biological triplicates. Asterisks represent significance values from unpaired t-tests as follows: **p 0.01, ns = not significant. (D) Western blot showing the loss of PK-resistant PrP Sc in the lysates from CAD5 cells chronically infected with 22L prions after siRNA knockdown of Stt3a , Stt3b , or Stt3a and Stt3b in combination.

Stt3a, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/stt3a/product/Proteintech
Average 94 stars, based on 1 article reviews

stt3a - by Bioz Stars, 2026-06

94/100 stars

Images

1) Product Images from "Oligosaccharyltransferase (OST) complex inhibition effectively treats rodent and human prions"

Article Title: Oligosaccharyltransferase (OST) complex inhibition effectively treats rodent and human prions

Journal: PLOS Pathogens

doi: 10.1371/journal.ppat.1013867

Figure Legend Snippet: (A) Western blot showing the amplification of PK-resistant PrP Sc from brain homogenate PMCA reactions supplemented with DMSO or NGI-1. (B) Representative flow cytometry plot showing effect of siRNA knockdown of Stt3a , Stt3b , or Stt3a and Stt3b combination on surface PrP C levels in WT CAD5 cells. (C) Quantification of flow cytometry PrP C surface expression in undifferentiated CAD5 cells treated with siRNAs targeted at Stt3a , Stt3b , or Stt3a and Stt3b in combination. Points represent individual samples from biological triplicates. Asterisks represent significance values from unpaired t-tests as follows: **p 0.01, ns = not significant. (D) Western blot showing the loss of PK-resistant PrP Sc in the lysates from CAD5 cells chronically infected with 22L prions after siRNA knockdown of Stt3a , Stt3b , or Stt3a and Stt3b in combination.

Techniques Used: Western Blot, Amplification, Flow Cytometry, Knockdown, Expressing, Infection

Image Search Results

(A) Western blot analysis of ASNS in metastatic cells isolated from bone (B-M-1, B-M-2) and lung (L-M-1, L-M-2) lesions. Vinculin was used as loading control. The image is representative of three independent experiments. (B) Schematic representation of asparaginyl-tRNA synthetase 1 (NARS1) mechanism of action. (C) NARS1 mRNA levels in PC3 cells following NARS1 silencing. Cells were transfected with NARS1-targeting small interfering RNA (siRNA) or negative control, and mRNA levels were evaluated after 5 days of incubation in 3D cultures (3D-C) by quantitative RT-PCR, using scramble-transfected cells as reference. (D) Relative cell number of PC3 cells silenced for NARS1 and cultured under standard 2D conditions for 5 days in the presence or absence of Asn (0.1 mM). One-way ANOVA with Sidak’s correction. (E-G) Number of putative N-glycosylation sites in proteins encoded by genes up- or down-regulated in metastatic cells derived from bone (E), lung (F), and liver (G) relative to primary tumor (PT). RNA-seq analysis was conducted as described in . Values are expressed relative to total protein number. (H-I) Fractional enrichment of UDP-GlcNAc isotopologues. PC3 cells were grown in 2D or 3D-C for 5 days and subsequently incubated in a medium containing U- 13 C-glucose for 24h. Labeling enrichment was evaluated by LC-MS analysis, and isotopologue abundance is reported as relative to total UDP-GlcNAc amount. Welch’s t test. (J) Labeling (m+5) enrichment of penotose phosphates from U- 13 C-glucose in PC3 cells growing in 2D or 3D-C for 5 days and subsequently incubated in a medium containing U- 13 C-glucose for 24h. Labeling enrichment was evaluated by LC-MS analysis. (K, L, P) Western blot analysis of GFPT1 (K), STT3a (L), and CD44 (P) expression in PC3 cells silenced for GFPT1, STT3a/b, and CD44 respectively after 48h of gene silencing. Vinculin was used as a loading control. The image is representative of three independent experiments. (M) Concanavalin A lectin binding assay performed on lysates from PC3 cells silenced or not for GFPT1 or STT3a/b and cultured in 3D-C for 5 days. Immunoblot for vinculin was used to confirm equal protein loading across samples. The image is representative of three independent experiments. (N-O) Adhesion of PC3 3D-C to collagen type I (L) and hyaluronic acid (M). Cells were cultured with Asn (0,1 mM) for 5 days and allowed to adhere for 15 min to plates coated with matrix components as reported. Adherent cells were quantified and data are shown relative to untreated cells. Welch’s t-test.

Journal: bioRxiv

Article Title: ASPARAGINE-RICH METASTATIC NICHES DRIVE PROSTATE CANCER ORGANOTROPISM BY ENABLING TRANSLATIONAL REWIRING TOWARD N-GLYCOSYLATED PROTEINS

doi: 10.64898/2026.02.27.708521

Figure Lengend Snippet: (A) Western blot analysis of ASNS in metastatic cells isolated from bone (B-M-1, B-M-2) and lung (L-M-1, L-M-2) lesions. Vinculin was used as loading control. The image is representative of three independent experiments. (B) Schematic representation of asparaginyl-tRNA synthetase 1 (NARS1) mechanism of action. (C) NARS1 mRNA levels in PC3 cells following NARS1 silencing. Cells were transfected with NARS1-targeting small interfering RNA (siRNA) or negative control, and mRNA levels were evaluated after 5 days of incubation in 3D cultures (3D-C) by quantitative RT-PCR, using scramble-transfected cells as reference. (D) Relative cell number of PC3 cells silenced for NARS1 and cultured under standard 2D conditions for 5 days in the presence or absence of Asn (0.1 mM). One-way ANOVA with Sidak’s correction. (E-G) Number of putative N-glycosylation sites in proteins encoded by genes up- or down-regulated in metastatic cells derived from bone (E), lung (F), and liver (G) relative to primary tumor (PT). RNA-seq analysis was conducted as described in . Values are expressed relative to total protein number. (H-I) Fractional enrichment of UDP-GlcNAc isotopologues. PC3 cells were grown in 2D or 3D-C for 5 days and subsequently incubated in a medium containing U- 13 C-glucose for 24h. Labeling enrichment was evaluated by LC-MS analysis, and isotopologue abundance is reported as relative to total UDP-GlcNAc amount. Welch’s t test. (J) Labeling (m+5) enrichment of penotose phosphates from U- 13 C-glucose in PC3 cells growing in 2D or 3D-C for 5 days and subsequently incubated in a medium containing U- 13 C-glucose for 24h. Labeling enrichment was evaluated by LC-MS analysis. (K, L, P) Western blot analysis of GFPT1 (K), STT3a (L), and CD44 (P) expression in PC3 cells silenced for GFPT1, STT3a/b, and CD44 respectively after 48h of gene silencing. Vinculin was used as a loading control. The image is representative of three independent experiments. (M) Concanavalin A lectin binding assay performed on lysates from PC3 cells silenced or not for GFPT1 or STT3a/b and cultured in 3D-C for 5 days. Immunoblot for vinculin was used to confirm equal protein loading across samples. The image is representative of three independent experiments. (N-O) Adhesion of PC3 3D-C to collagen type I (L) and hyaluronic acid (M). Cells were cultured with Asn (0,1 mM) for 5 days and allowed to adhere for 15 min to plates coated with matrix components as reported. Adherent cells were quantified and data are shown relative to untreated cells. Welch’s t-test.

Article Snippet: Membranes were incubated for 1h at room temperature in blocking buffer (5% non-fat dry milk (SantaCruz Biotechnology #sc-2325) in PBS-Tween 0.1%), and then incubated at 4°C over-night with primary antibodies against either ATF-4 (Cell Signaling Technology #11815), ASNS (Cell Signaling Technology #92479S), Phospho-mTOR (Ser2448) (Cell Signaling Technology #5536S), mTOR (Cell Signaling Technology #2983), Phospho-S6K1(Thr389) (Cell Signalig Technology #9205), S6K1 (Cell Signaling Technology #9202), CD44 (Cell Signaling Technology #3570), GFPT1 (ABClonal #A20873), STT3a (Santa Cruz Biotechology #sc-390227), Vinculin (Santa Cruz Biotechology #sc-59803), β-Actin (Santa Cruz Biotechology #sc-47778).

Techniques: Western Blot, Isolation, Control, Transfection, Small Interfering RNA, Negative Control, Incubation, Quantitative RT-PCR, Cell Culture, Glycoproteomics, Derivative Assay, RNA Sequencing, Labeling, Liquid Chromatography with Mass Spectroscopy, Expressing, Binding Assay

(A-C) Number of putative N-glycosylation sites in proteins encoded by genes upregulated in bone-(A), lung-(B), and liver-(C) derived metastatic cells relative to the primary tumor (PT). RNA-seq analysis was conducted as described in . Values are expressed as relative to proteins number. Welch’s t-test. (D) Number of putative N-glycosylation sites in proteins encoded by genes upregulated in bone-, lung-, and liver-derived metastatic cells. One-way ANOVA with Tukey’s correction. (E) Relative incorporation of U- 13 C-glucose carbons in UDP-N-acetyl-glucosamine. PC3 cells were grown in 3D-C for 5 days and subsequently incubated in a medium containing U- 13 C-glucose for 24h. Metabolite abundance and labeling enrichment were evaluated by LC-MS analysis. (F) mRNA levels of oligosaccharyltransferase (OST) in 2D coltures and 3D-C. mRNA expression levels analyzed by quantitative RT-PCR using 2D condition as comparator. Student’s t test. (G) Concanavalin A lectin binding assay performed on lysates from PC3 cells cultured in 2D conditions or 3D-C, with or without Asn supplementation (0.1 mM). Immunoblot for actin was used to confirm equal protein loading across samples. The image is representative of three independent experiments. (H) Concanavalin A lectin binding assay performed on lysates from 3D-C cultured with or without Asn (0.1 mM) in the presence or absence of L-asparaginase (ASNase, 0.25 U/ml). Immunoblot for vinculin was used to confirm equal protein loading across samples. The image is representative of three independent experiments. (I) Total spheroid area of PC3 3D-C grown with or without Asn (0.1 mM) in the presence or absence of Tunicamycin (5ng/µl). One-way ANOVA with Dunnett’s correction. (J) Total spheroid area of Glutamine-fructose-6-phosphate transaminase 1 (GFPT1)-silenced PC3 cells grown in 3D-C with or without Asn (0.1 mM). One-way ANOVA with Dunnett’s correction. (K) Total spheroid area of 3D-C PC3 cells silenced for the OST catalytic subunits STT3A and STT3B with or without Asn (0.1 mM). One-way ANOVA with Dunnett’s correction. (L) Concanavalin A lectin binding assay performed on lysates from liver-derived (Liv-M), bone-derived (B-M-1, B-M-2) and lung-derived (L-M-1, L-M-2) metastatic cells (obtained after intracardiac or caudal artery injection, respectively) grown in 3D-C cultures. Immunoblot for vinculin was used to confirm equal protein loading across samples. The image is representative of three independent experiments. (M-P) Total spheroid area of bone-derived (M, N), and lung-derived (O, P) metastatic cells grown in 3D-C cultures with or without Asn (0.1 mM) in the presence or absence of Tunicamycin (5ng/µl). Two-way ANOVA with Tukey’s correction. ns, not significant; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. Data represent mean ± s.e.m. from at least three independent experiments.

Journal: bioRxiv

Article Title: ASPARAGINE-RICH METASTATIC NICHES DRIVE PROSTATE CANCER ORGANOTROPISM BY ENABLING TRANSLATIONAL REWIRING TOWARD N-GLYCOSYLATED PROTEINS

doi: 10.64898/2026.02.27.708521

Figure Lengend Snippet: (A-C) Number of putative N-glycosylation sites in proteins encoded by genes upregulated in bone-(A), lung-(B), and liver-(C) derived metastatic cells relative to the primary tumor (PT). RNA-seq analysis was conducted as described in . Values are expressed as relative to proteins number. Welch’s t-test. (D) Number of putative N-glycosylation sites in proteins encoded by genes upregulated in bone-, lung-, and liver-derived metastatic cells. One-way ANOVA with Tukey’s correction. (E) Relative incorporation of U- 13 C-glucose carbons in UDP-N-acetyl-glucosamine. PC3 cells were grown in 3D-C for 5 days and subsequently incubated in a medium containing U- 13 C-glucose for 24h. Metabolite abundance and labeling enrichment were evaluated by LC-MS analysis. (F) mRNA levels of oligosaccharyltransferase (OST) in 2D coltures and 3D-C. mRNA expression levels analyzed by quantitative RT-PCR using 2D condition as comparator. Student’s t test. (G) Concanavalin A lectin binding assay performed on lysates from PC3 cells cultured in 2D conditions or 3D-C, with or without Asn supplementation (0.1 mM). Immunoblot for actin was used to confirm equal protein loading across samples. The image is representative of three independent experiments. (H) Concanavalin A lectin binding assay performed on lysates from 3D-C cultured with or without Asn (0.1 mM) in the presence or absence of L-asparaginase (ASNase, 0.25 U/ml). Immunoblot for vinculin was used to confirm equal protein loading across samples. The image is representative of three independent experiments. (I) Total spheroid area of PC3 3D-C grown with or without Asn (0.1 mM) in the presence or absence of Tunicamycin (5ng/µl). One-way ANOVA with Dunnett’s correction. (J) Total spheroid area of Glutamine-fructose-6-phosphate transaminase 1 (GFPT1)-silenced PC3 cells grown in 3D-C with or without Asn (0.1 mM). One-way ANOVA with Dunnett’s correction. (K) Total spheroid area of 3D-C PC3 cells silenced for the OST catalytic subunits STT3A and STT3B with or without Asn (0.1 mM). One-way ANOVA with Dunnett’s correction. (L) Concanavalin A lectin binding assay performed on lysates from liver-derived (Liv-M), bone-derived (B-M-1, B-M-2) and lung-derived (L-M-1, L-M-2) metastatic cells (obtained after intracardiac or caudal artery injection, respectively) grown in 3D-C cultures. Immunoblot for vinculin was used to confirm equal protein loading across samples. The image is representative of three independent experiments. (M-P) Total spheroid area of bone-derived (M, N), and lung-derived (O, P) metastatic cells grown in 3D-C cultures with or without Asn (0.1 mM) in the presence or absence of Tunicamycin (5ng/µl). Two-way ANOVA with Tukey’s correction. ns, not significant; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. Data represent mean ± s.e.m. from at least three independent experiments.

Techniques: Glycoproteomics, Derivative Assay, RNA Sequencing, Incubation, Labeling, Liquid Chromatography with Mass Spectroscopy, Expressing, Quantitative RT-PCR, Binding Assay, Cell Culture, Western Blot, Injection

Journal: PLOS Pathogens

Article Title: Oligosaccharyltransferase (OST) complex inhibition effectively treats rodent and human prions

doi: 10.1371/journal.ppat.1013867

Figure Lengend Snippet: (A) Western blot showing the amplification of PK-resistant PrP Sc from brain homogenate PMCA reactions supplemented with DMSO or NGI-1. (B) Representative flow cytometry plot showing effect of siRNA knockdown of Stt3a , Stt3b , or Stt3a and Stt3b combination on surface PrP C levels in WT CAD5 cells. (C) Quantification of flow cytometry PrP C surface expression in undifferentiated CAD5 cells treated with siRNAs targeted at Stt3a , Stt3b , or Stt3a and Stt3b in combination. Points represent individual samples from biological triplicates. Asterisks represent significance values from unpaired t-tests as follows: **p 0.01, ns = not significant. (D) Western blot showing the loss of PK-resistant PrP Sc in the lysates from CAD5 cells chronically infected with 22L prions after siRNA knockdown of Stt3a , Stt3b , or Stt3a and Stt3b in combination.

Article Snippet: Western blot was performed on cell lysate to assess PK-resistant PrP Sc as described above or to assess knockdown efficiency of STT3A or STT3B using STT3A monoclonal antibody 1E2B12 (Proteintech, Rosemont, IL, USA) or STT3B polyclonal antibody (Proteintech, Cat # 15323–1-AP) as primary antibodies and horseradish peroxidase-labeled sheep-anti-mouse secondary antibody (Cytiva) or goat-anti-rabbit secondary antibody (BioRad, Hercules, CA, USA, Cat # 1706515) at manufacturers’ recommended dilutions

Techniques: Western Blot, Amplification, Flow Cytometry, Knockdown, Expressing, Infection

Journal: PLOS Pathogens

Article Title: Oligosaccharyltransferase (OST) complex inhibition effectively treats rodent and human prions

doi: 10.1371/journal.ppat.1013867

Techniques: Western Blot, Amplification, Flow Cytometry, Knockdown, Expressing, Infection

Review

Structured Review

Images

1) Product Images from "Oligosaccharyltransferase (OST) complex inhibition effectively treats rodent and human prions"

Similar Products

Image Search Results